| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/17/2005 | WO2005014629A2 Protein from photobacterium damselae and use thereof |
| 02/17/2005 | WO2005014628A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof. |
| 02/17/2005 | WO2005014627A1 Recombinant dengue multi epitope proteins as diagnostic intermediates |
| 02/17/2005 | WO2005014624A2 Preparation of somatostatin peptides |
| 02/17/2005 | WO2005014623A2 Compounds comprising lpa |
| 02/17/2005 | WO2005014622A2 Ra antigenic peptides |
| 02/17/2005 | WO2005014621A1 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain |
| 02/17/2005 | WO2005014619A2 Heparin-binding peptides and uses thereof |
| 02/17/2005 | WO2005014617A2 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 02/17/2005 | WO2005014616A2 Complexes of gpcr142 and relaxin3 or insl5, and their production and use |
| 02/17/2005 | WO2005014615A2 Self-assembling peptides incorporating modifications and methods of use thereof |
| 02/17/2005 | WO2005014612A1 Novel splice variant of ctla-4 |
| 02/17/2005 | WO2005014039A2 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative diseases |
| 02/17/2005 | WO2005014029A2 Use of dg008, dg065, dg210 or dg 239 secreted protein products for preventing and treating pancreatic diseases, obesity or metabolic syndrome |
| 02/17/2005 | WO2005013918A2 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 02/17/2005 | WO2005013916A2 Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/pin in human cells |
| 02/17/2005 | WO2005013904A2 Sars nucleic acids, proteins, vaccines, and uses thereof |
| 02/17/2005 | WO2005013899A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/17/2005 | WO2005013898A2 Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax |
| 02/17/2005 | WO2005013889A2 Truncated fragments of alpha-synuclein in lewy body disease |
| 02/17/2005 | WO2005013802A2 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 02/17/2005 | WO2005013682A2 Animal model for the analysis of tumor metastasis |
| 02/17/2005 | WO2004113547A3 Potent combinations of mrna transport elements |
| 02/17/2005 | WO2004111082A3 Compound containing polyprotein ns3/ns4 and hcv polypeptide ns5b, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof |
| 02/17/2005 | WO2004108883A3 Transducible dna-binding proteins |
| 02/17/2005 | WO2004106369A3 Complement inhibitors from ticks |
| 02/17/2005 | WO2004089072A8 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene |
| 02/17/2005 | WO2004087730A8 Method for producing diverse libraries of encoded polymers |
| 02/17/2005 | WO2004083398A3 Therapeutic uses of hmgn1 and hmgn2 |
| 02/17/2005 | WO2004083397A3 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
| 02/17/2005 | WO2004081189A9 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and organisms |
| 02/17/2005 | WO2004081028A3 Allergen peptide fragments and use thereof |
| 02/17/2005 | WO2004074432A3 Antibody vaccine conjugates and uses therefor |
| 02/17/2005 | WO2004067564A3 Compositions against cancer antigen liv-1 and uses thereof |
| 02/17/2005 | WO2004067548B1 Chemically modified metabolites of regulatory peptides and methods of producing and using same |
| 02/17/2005 | WO2004054350A3 Generation of plants with altered oil content |
| 02/17/2005 | WO2004047740A3 Composition and method for treating lupus nephritis |
| 02/17/2005 | WO2004046310A3 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 02/17/2005 | WO2004044126A3 Novel proteins and their uses |
| 02/17/2005 | WO2004033471A3 Glucose transport mutants for production of biomaterial |
| 02/17/2005 | WO2004031364A3 Proteins associated with cell growth, differentiation, and death |
| 02/17/2005 | WO2004020457A3 Methods and compositions for the inhibition of dna repair protein xrcc-3 |
| 02/17/2005 | WO2004008099A8 METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 02/17/2005 | WO2003104412A3 Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects |
| 02/17/2005 | WO2003102156B1 Heterologous stimulus-gated ion channels and methods of using same |
| 02/17/2005 | WO2003101396A3 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 02/17/2005 | WO2003070916A3 Dna encoding snorf44 receptor |
| 02/17/2005 | WO2003070187A3 Fusion proteins of mycobacterium tuberculosis |
| 02/17/2005 | WO2003050258A3 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/17/2005 | WO2003038051A3 Method of inducing apoptosis in hyperproliferative cells |
| 02/17/2005 | WO2003033675A3 Identification of binding partners for specific proteins |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | WO2002088304A3 Compositions and methods for suppressing immune responses |
| 02/17/2005 | WO2002083714A3 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | WO2002010430A3 Detecting anti-viral drug candidates and resistance |
| 02/17/2005 | US20050039235 Transforming plant with expression vector comprising regulatory nucleotide sequences and gene sequences associated with expression if insulin in endoplasmic reticulum of flax, safflower and/or arabidopsis |
| 02/17/2005 | US20050039232 DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses |
| 02/17/2005 | US20050039228 Methods and compositions for analysis of plant gene function |
| 02/17/2005 | US20050039227 Nucleic acid encoding GAI gene of Arabidopsis thaliana |
| 02/17/2005 | US20050039223 Knock-in-mouse |
| 02/17/2005 | US20050039220 Labeled coronavirus protein for use as diagnostic tool in detection of viral infection; viricides and vaccine development for treatment and prevention of respiratory system disorders |
| 02/17/2005 | US20050038611 S8 rrna-binding protein from the small ribosomal subunit of staphylococcus aureus |
| 02/17/2005 | US20050038610 Apparatus and method for automated protein design |
| 02/17/2005 | US20050038234 Bi-functionalised metallocenes use for marking biological molecules |
| 02/17/2005 | US20050038233 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight |
| 02/17/2005 | US20050038230 For decreasing food intake; eating disorders; sexual disorders |
| 02/17/2005 | US20050038229 Protein scaffolds for antibody mimics and other binding proteins |
| 02/17/2005 | US20050038228 Makes it possible to selectively adsorb an immunoglobulin and/or an immune complex present in a body fluid (for example, blood, plasma, etc.) efficiently without pretreating the body fluid |
| 02/17/2005 | US20050038019 Hydroxy substituted amides for the treatment of alzheimer's disease |
| 02/17/2005 | US20050037986 p53 treatment of papillomavirus and carcinogen-transformed cells in hyperplastic lesions |
| 02/17/2005 | US20050037974 E-Ca R Cb-A, in which E is a diagnostic agent, R is a reactive group, Cb and Ca are optional first and second connecting groups, and A is an affinity group that is any molecule or part of a molecule possessing specific binding determinants for a target molecule |
| 02/17/2005 | US20050037973 Compounds and methods for cancer therapy |
| 02/17/2005 | US20050037972 Bactericides; using polypeptides |
| 02/17/2005 | US20050037970 Protein devived from Schistosome parasites |
| 02/17/2005 | US20050037969 Molecular interactions in hematopoietic cells |
| 02/17/2005 | US20050037968 Peptide leukotriene receptor |
| 02/17/2005 | US20050037967 conjugate is cytotoxic to cells expressing more than 2000 type 2 VEGF receptors per celll fusion protein with cytotoxic molecule such as gelonin or granzyme B or Bax |
| 02/17/2005 | US20050037966 Keratinocyte growth factor-2 |
| 02/17/2005 | US20050037962 Modulating angiogenesis by modulating gene expression or activation of syndecan-2; antitumor agents |
| 02/17/2005 | US20050037959 Low white blood cell titer |
| 02/17/2005 | US20050037957 Polypeptide as target of drugs to detect central nervous system disorders, cancer, metabolism and cardiovascular disorders |
| 02/17/2005 | US20050037955 Bactericides; fungicides; isolated polypeptides; inflammatory bowel disorders; infections |
| 02/17/2005 | US20050037951 Composition and methods for treatment of sexual dysfunction |
| 02/17/2005 | US20050037949 Mannose binding lectin and uses thereof |
| 02/17/2005 | US20050037948 Calcium phosphopeptide complexes |
| 02/17/2005 | US20050037946 Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 41922, 2552, 2417, 19319, 43969, 8921, 8993, 955, 32345, 966, 1920, 17318, 1510, 14180, 26005, 554, 16408, 42028, 112091, 13886, 13942, 1673, 54946 or 2419 |
| 02/17/2005 | US20050037479 Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making |
| 02/17/2005 | US20050037477 Chaperone proteins for use in identifying modulator for treatment and prevention of autoimmune disorders |
| 02/17/2005 | US20050037475 Method of purifying TFPI and TFPI analogs |
| 02/17/2005 | US20050037474 Method for controlling the yield and purity of proteinase inhibitor II during extraction |
| 02/17/2005 | US20050037469 Fusion polypeptide comprising a collagen-binding domain and an epithelial cell proliferation-modulating domain for use as tool in regenerative medicine and tissue repair |
| 02/17/2005 | US20050037468 Expression vector comprising nucleotide sequences coding g protein coupled receptor for use in identifying modulator for use in treatment and prevention of pain; antinociceptive agents |
| 02/17/2005 | US20050037467 83 human secreted proteins |
| 02/17/2005 | US20050037466 Membrane protein for use in identifying modulators for prevention and treatment of diagnosis, treatment, and prevention of neurological, immunological and cell proliferative disorders |
| 02/17/2005 | US20050037465 Novel secreted polypeptide and methods of treatment of bone disorders |
| 02/17/2005 | US20050037464 Prokineticin polypeptides, related compositions and methods |
| 02/17/2005 | US20050037463 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/17/2005 | US20050037462 Expression vector comprising nucleotide sequences coding g protein for use in generating immunoglobulins for use in prevention, treatment and diagnosis of cell proliferative disorders |
| 02/17/2005 | US20050037461 Expression vector comprising nucleotide sequences coding chaperone protein for use in generating immunoglobulin fo use in detection prevention and treatment of cell proliferative and inflammatory disorders |